1. Petty R. E., Southwood T. R., Manners P., Baum J., Glass D. N., Goldenberg J., He X., Maldonado-Cocco J., Orozco-Alcala J., Prieur A. M., Suarez-Almazor M.E., Woo P.; International League of Associations for Rheumatology.International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004 Feb;31(2):390-2.
2. Petty R. E., Laxer R. M., Lindsley C., Wedderburn L. R. Textbook of pediatric rheumatology. 7th edition. Philadelphia: Saunders; 2016.
3. Calvo I., Anton J., Lopez Robledillo J. C. et al. Recommendations for the use of methotrexate in patients with juvenile idiopathic arthritis. An Pediatr (Barc). 2016 Mar; 84(3):177.e1-8. doi: 10.1016/j.anpedi. 2015.05.005.
4. Nasonov E. L. Methotrexate for rheumatoid arthritis - 2015: new facts and ideas. Scientific and practical rheumatology. 2015;53(5):61-64. (in Russ.)@@ Nasonov E. L. Metotreksat pri revmatoidnom artrite - 2015: novye fakty i idei // Nauchno-prakticheskaya revmatologiya. - 2015. - T. 53, № 5. - S. 61-64.
5. Ravelli A., Consolaro A., Horneff G. et al. Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2018;77(6):819-828. doi: 10.1136/ annrheumdis-2018-21303.